Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Anemarsaponin B has anti-inflammatory effect in LPS-treated RAW 264.7macrophages, the effect is associated with the inhibition of NF-κB transcriptional activity, possibly via the p38 MAP kinase pathway. Anemarsaponin B can inhibit PAF-induced rabbit platelet aggregation in vitro.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 84.00 | |
5 mg | In stock | $ 196.00 | |
10 mg | In stock | $ 295.00 | |
25 mg | In stock | $ 497.00 | |
50 mg | In stock | $ 723.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 327.00 |
Description | Anemarsaponin B has anti-inflammatory effect in LPS-treated RAW 264.7macrophages, the effect is associated with the inhibition of NF-κB transcriptional activity, possibly via the p38 MAP kinase pathway. Anemarsaponin B can inhibit PAF-induced rabbit platelet aggregation in vitro. |
Source |
Molecular Weight | 903.06 |
Formula | C45H74O18 |
CAS No. | 139051-27-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 27.5 mg/mL (30.45 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
anemarsaponin B 139051-27-7 Immunology/Inflammation MAPK Neuroscience NF-Κb p38 MAPK NF-κB NO Synthase COX MEK Nuclear factor-kappaB MAP2K Mitogen-activated protein kinase kinase MAPKK Nuclear factor-κB NOS Cyclooxygenase Inhibitor Nitric oxide synthases inhibit inhibitor